Yoon, J.-J.; Tai, A.-L.; Kim, H.-Y.; Han, B.-H.; Shin, S.; Lee, H.-S.; Kang, D.-G.
TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. Int. J. Mol. Sci. 2024, 25, 10573.
https://doi.org/10.3390/ijms251910573
AMA Style
Yoon J-J, Tai A-L, Kim H-Y, Han B-H, Shin S, Lee H-S, Kang D-G.
TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. International Journal of Molecular Sciences. 2024; 25(19):10573.
https://doi.org/10.3390/ijms251910573
Chicago/Turabian Style
Yoon, Jung-Joo, Ai-Lin Tai, Hye-Yoom Kim, Byung-Hyuk Han, Sarah Shin, Ho-Sub Lee, and Dae-Gill Kang.
2024. "TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways" International Journal of Molecular Sciences 25, no. 19: 10573.
https://doi.org/10.3390/ijms251910573
APA Style
Yoon, J.-J., Tai, A.-L., Kim, H.-Y., Han, B.-H., Shin, S., Lee, H.-S., & Kang, D.-G.
(2024). TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. International Journal of Molecular Sciences, 25(19), 10573.
https://doi.org/10.3390/ijms251910573